Neuroimaging in mitochondrial disease.

Area of Science:

• Neuroscience
• Biochemistry
• Medical Imaging

Background:

• The brain's high energy demand and complex structure make it vulnerable to mitochondrial oxidative phosphorylation defects, leading to neurodegeneration.
• Mitochondrial diseases manifest with selective regional vulnerability and distinct patterns of brain damage, exemplified by Leigh syndrome (basal ganglia/brain stem) and MELAS syndrome (focal lesions).
• Both gray and white matter can be affected, with white matter lesions potentially progressing to cystic cavities, depending on the specific genetic defect.

Approach:

• Neuroimaging techniques, primarily magnetic resonance imaging (MRI) and MR spectroscopy (MRS), are essential for diagnosing mitochondrial diseases.
• MRI visualizes anatomical changes, while MRS detects metabolites like lactate, a key indicator of mitochondrial dysfunction.
• The review covers the spectrum of neuroimaging findings and discusses critical differential diagnoses that can mimic mitochondrial disease presentations.

Key Points:

• Neuroimaging findings such as symmetric basal ganglia lesions or lactate peaks on MRS are not pathognomonic and can be observed in other disorders.
• Recognizing specific patterns of brain damage is vital for the diagnostic work-up of suspected mitochondrial diseases.
• Understanding the limitations of current neuroimaging is important for accurate diagnosis and considering alternative conditions.

Conclusions:

• Neuroimaging plays a pivotal role in the diagnostic pathway for mitochondrial diseases, offering insights into brain pathology.
• While MRI and MRS are mainstays, their findings require careful interpretation due to overlapping features with other neurological conditions.
• Future research into novel biomedical imaging tools promises to enhance our understanding of mitochondrial disease pathophysiology.